WO1998042390A1 - Method of surface oxidizing zirconium alloys and resulting product - Google Patents

Method of surface oxidizing zirconium alloys and resulting product Download PDF

Info

Publication number
WO1998042390A1
WO1998042390A1 PCT/US1998/006059 US9806059W WO9842390A1 WO 1998042390 A1 WO1998042390 A1 WO 1998042390A1 US 9806059 W US9806059 W US 9806059W WO 9842390 A1 WO9842390 A1 WO 9842390A1
Authority
WO
WIPO (PCT)
Prior art keywords
zirconium
prosthesis
black
blue
prosthesis body
Prior art date
Application number
PCT/US1998/006059
Other languages
French (fr)
Inventor
Gordon Hunter
Catherine M. Asgian
Gary L. Hines
Original Assignee
Smith & Nephew, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith & Nephew, Inc. filed Critical Smith & Nephew, Inc.
Priority to DE69825570T priority Critical patent/DE69825570T2/en
Priority to AT98912091T priority patent/ATE273036T1/en
Priority to JP54601598A priority patent/JP4491076B2/en
Priority to US09/381,217 priority patent/US6447550B1/en
Priority to AU65889/98A priority patent/AU736216B2/en
Priority to EP98912091A priority patent/EP0968011B1/en
Priority to CA002284816A priority patent/CA2284816C/en
Publication of WO1998042390A1 publication Critical patent/WO1998042390A1/en
Priority to US09/909,612 priority patent/US6585772B2/en
Priority to US10/382,228 priority patent/US7070623B2/en
Priority to US11/431,764 priority patent/US7582117B2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C8/00Solid state diffusion of only non-metal elements into metallic material surfaces; Chemical surface treatment of metallic material by reaction of the surface with a reactive gas, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals
    • C23C8/06Solid state diffusion of only non-metal elements into metallic material surfaces; Chemical surface treatment of metallic material by reaction of the surface with a reactive gas, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals using gases
    • C23C8/08Solid state diffusion of only non-metal elements into metallic material surfaces; Chemical surface treatment of metallic material by reaction of the surface with a reactive gas, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals using gases only one element being applied
    • C23C8/10Oxidising
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/04Metals or alloys
    • A61L27/047Other specific metals or alloys not covered by A61L27/042 - A61L27/045 or A61L27/06
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/30Inorganic materials
    • A61L27/306Other specific inorganic materials not covered by A61L27/303 - A61L27/32
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C8/00Solid state diffusion of only non-metal elements into metallic material surfaces; Chemical surface treatment of metallic material by reaction of the surface with a reactive gas, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals
    • C23C8/02Pretreatment of the material to be coated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • A61F2/2803Bones for mandibular reconstruction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/34Acetabular cups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • A61F2/3662Femoral shafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • A61F2/3662Femoral shafts
    • A61F2/367Proximal or metaphyseal parts of shafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/38Joints for elbows or knees
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/38Joints for elbows or knees
    • A61F2/3859Femoral components
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/38Joints for elbows or knees
    • A61F2/389Tibial components
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/40Joints for shoulders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/42Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes
    • A61F2/4241Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes for hands, e.g. fingers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30316The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30317The prosthesis having different structural features at different locations within the same prosthesis
    • A61F2002/30322The prosthesis having different structural features at different locations within the same prosthesis differing in surface structures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30316The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30329Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2002/30331Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements made by longitudinally pushing a protrusion into a complementarily-shaped recess, e.g. held by friction fit
    • A61F2002/30332Conically- or frustoconically-shaped protrusion and recess
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30771Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
    • A61F2002/30838Microstructures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30771Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
    • A61F2002/30878Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves with non-sharp protrusions, for instance contacting the bone for anchoring, e.g. keels, pegs, pins, posts, shanks, stems, struts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30771Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
    • A61F2002/30878Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves with non-sharp protrusions, for instance contacting the bone for anchoring, e.g. keels, pegs, pins, posts, shanks, stems, struts
    • A61F2002/30891Plurality of protrusions
    • A61F2002/30892Plurality of protrusions parallel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30907Nets or sleeves applied to surface of prostheses or in cement
    • A61F2002/30909Nets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • A61F2/3609Femoral heads or necks; Connections of endoprosthetic heads or necks to endoprosthetic femoral shafts
    • A61F2002/3611Heads or epiphyseal parts of femur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • A61F2/3609Femoral heads or necks; Connections of endoprosthetic heads or necks to endoprosthetic femoral shafts
    • A61F2002/3625Necks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • A61F2/3609Femoral heads or necks; Connections of endoprosthetic heads or necks to endoprosthetic femoral shafts
    • A61F2002/365Connections of heads to necks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0033Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements made by longitudinally pushing a protrusion into a complementary-shaped recess, e.g. held by friction fit
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0026Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in surface structures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00011Metals or alloys
    • A61F2310/00035Other metals or alloys
    • A61F2310/00089Zirconium or Zr-based alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00389The prosthesis being coated or covered with a particular material
    • A61F2310/00592Coating or prosthesis-covering structure made of ceramics or of ceramic-like compounds
    • A61F2310/00598Coating or prosthesis-covering structure made of compounds based on metal oxides or hydroxides
    • A61F2310/00634Coating made of zirconium oxide or hydroxides

Definitions

  • This invention relates to metallic orthopedic implants with load bearing surfaces coated with a thin, dense, low friction, highly wear-resistant, uniformly thick coating of zirconium oxide.
  • the invention also relates to uniformly thick zirconium oxide coatings on the non-load bearing surfaces of an orthopedic implant where the zirconium oxide provides a barrier between the metallic prosthesis and body tissue thereby preventing the release of metal ions and corrosion of the implant.
  • the invention also relates to a method of producing a uniformly thick oxide coating on zirconium or a zirconium alloy by controlling the surface roughness of the zirconium or zirconium alloy having a refined microstructure prior to formation of the oxide coating.
  • the excellent corrosion resistance of zirconium has been known for many years. Zirconium displays excellent corrosion resistance in many aqueous and non- aqueous media and for this reason has seen an increased use in the chemical process industry and in medical applications.
  • a limitation to the wider application of zirconium in these areas is its relatively low resistance to abrasion and its tendency to gall. This relatively low resistance to abrasion and the tendency to gall is also demonstrated in zirconium alloys.
  • Orthopedic implant materials must combine high strength, corrosion resistance and tissue compatibility.
  • the longevity of the implant is of prime importance especially if the recipient of the implant is relatively young because it is desirable that the implant function for the complete lifetime of a patient.
  • certain metal alloys have the required mechanical strength and biocompatibility, they are ideal candidates for the fabrication of prostheses. These alloys include 316L stainless steel, chrome-cobalt-molybdenum alloys and, more recently, titanium alloys which have proven to be the most suitable materials for the fabrication of load-bearing prostheses.
  • One of the variables affecting the longevity of load-bearing implants, such as hip joint implants, is the rate of wear of the articulating surfaces and long-term effects of the metal ion release.
  • a typical hip joint prosthesis includes a stem, a femoral head and an acetabular cup against which the femoral head articulates. Wear of either or both of the articulating surfaces results in an increasing level of wear particulates and "play" between the femoral head and the cup against which it articulates. Wear debris can contribute to adverse tissue rejection leading to bone resorption, and ultimately the joint must be replaced. The rate of wear is dependent upon a number of factors which include the relative hardness and surface finish of the material which constitute the femoral head and the acetabular cup, the frictional coefficient between the materials of the cup and head, the load applied and the stresses generated at the articulating surface.
  • the most common material combinations currently used in fabrication of hip joints implants include femoral heads of cobalt or titanium alloys articulating against acetabular cups lined with organic polymers or composites of such polymers including, e.g., ultra high molecular weight polyethylene (UHMWPE), and femoral heads of polished alumina in combination with acetabular cups lined with an organic polymer or composite or cups made of polished alumina.
  • UHMWPE ultra high molecular weight polyethylene
  • femoral heads of polished alumina in combination with acetabular cups lined with an organic polymer or composite or cups made of polished alumina.
  • UHMWPE being a polymeric material
  • UHMWPE is more susceptible to creep when heated than the commonly used metal alloys or ceramics and is consequently more susceptible to wear than the alloys or ceramics.
  • metal prostheses are not completely inert in the body. Body fluids act upon the metals causing them to slowly corrode by an ionizing process that thereby releases metal ions into the body. Metal ion release from the prosthesis is also related to the rate of wear of load bearing surfaces because the passive oxide film, which is formed on the surface, is constantly removed. The repassivation process constantly releases metal ions during the ionizing process.
  • third-body wear cement or bone debris accelerates this process and microfretted metal particles increase friction. Consequently, the
  • Suzuki patent did not address the issue of friction or wear of orthopedic implant bearing surfaces but confined itself to the single issue of the biocompatibility of metal prostheses. Furthermore, Suzuki et al. did not address the issue of dimensional changes that occur when applying a coating or the effect of these dimensional changes in the tightness of fit between the surfaces of an articulating joint prosthesis.
  • U.S. Patent No. 2,987,352 to Watson discloses a method of producing a blue- black oxide coating on zirconium alloy parts for the purpose of increasing their abrasion resistance.
  • Both U.S. Patent 2,987,352 and U.S. Patent 3,615,885 produce a zirconium dioxide coating on zirconium alloy by means of air oxidation.
  • U.S. Patent 3,615,885 continues the air oxidation long enough to produce a beige coating of greater thickness than the blue-black coating of U.S. Patent No. 2,987,352. This beige coating does not have the wear resistance of the blue-black coating and is thus not applicable to many parts where there are two work faces in close proximity.
  • the beige coating wears down more quickly than the blue-black oxide coating with the resulting formation of zirconium oxide particles and the loss of the integrity of the zirconium oxide surface. With the loss of the oxide surface the zirconium metal is then exposed to its environment and can lead to transport of zirconium ions away from the surface of the metal into the adjacent environment.
  • the blue-black oxide coatings have a thickness which is less than that of the beige coating although the hardness of the blue-black coating is higher than that of the beige coating. This harder blue-black oxide coating lends itself better to surfaces such as prosthetic devices. Although the blue-black coating is more abrasion resistant than the beige coating it is a relatively thin coating. It is therefore desirable to produce the blue-black coatings of increased abrasion resistance without producing the same type coatings of the prior art.
  • the oxide coating produced is not always uniform in thickness and the non- uniformity reduces the integrity of the bonding between the zirconium alloy and the oxide layer and the integrity of the bonding within the oxide layer.
  • the invention provides a method for forming a uniformly thick oxide coating on zirconium or a zirconium alloy, each having a refined microstructure, by inducing an altered surface roughness on the zirconium or zirconium alloy, prior to oxidizing the zirconium or zirconium alloy to form a blue-black zirconium oxide coating of uniform and controlled thickness.
  • the invention also provides a method for forming a uniformly thick oxide coating on a zirconium or zirconium alloy prosthesis, for implantation in a patient, by inducing an altered surface roughness on at least a portion of the zirconium or zirconium alloy prosthesis, wherein the zirconium or zirconium oxide has a refined microstructure, prior to oxidizing the prosthesis to form a blue-black zirconium oxide coating of uniform and controlled thickness on at least a portion of the surface of the prosthesis.
  • Figure 1 is a schematic diagram depicting a hip joint prosthesis in position.
  • Figure 2 is a schematic diagram showing a typical hip joint prosthesis.
  • Figure 3 is a schematic diagram of a knee joint prosthesis in place.
  • Figure 4 is a schematic diagram of the parts of a typical knee joint.
  • One aspect of the present invention is to provide a method for forming an oxide coating of uniform thickness on zirconium or a zirconium alloy, the zirconium or zirconium alloy each having a refined microstructure and an altered surface roughness.
  • Another aspect of the present invention is to provide a low friction, wear resistant oxide coating of uniform thickness on prosthesis surfaces, such as articulating surfaces and irregular surface structures adapted to accommodate tissue ingrowth on a portion of the prosthesis body.
  • the here-claimed method of forming an oxide coating of uniform thickness by inducing an altered surface roughness on zirconium or a zirconium alloy, each having a refined microstructure, prior to oxidizing the zirconium or zirconium alloy is applicable to various prosthetic parts and devices.
  • These prosthetic parts and devices include, but are not limited to, cardiovascular implants including heart valves, total artificial heart implants, ventricular assist devices, vascular grafts and stents; electrical signal carrying devices such as pacemaker and neurological leads, and defibrillator leads; guide wires and catheters; percutaneous devices; and joint prostheses including hip joints or surface replacements, knee joints, shoulder joints, elbows, endoprostheses, spinal segments, and fingers. Illustrative examples of such articulating surfaces are shown in the schematic diagrams, Figures 1-4.
  • a typical hip joint assembly is shown in situ in Figure 1.
  • the hip joint stem 2 fits into the femur while the femoral head 6 of the prosthesis fits into and articulates against the inner lining 8 of an acetabular cup 10 which in turn is affixed to the pelvis as shown in Figure 1.
  • a porous metal bead or wire mesh coating 12 may be incorporated to allow stabilization of the implant by ingrowth of surrounding tissue into the porous coating. Similarly, such a porous metal bead or wire mesh coating can also be applied to the acetabular component.
  • the femoral head 6 may be an integral part of the hip joint stem 2 or may be a separate component mounted upon a conical taper at the end of the neck 4 of the hip joint prosthesis.
  • the knee joint includes a femoral component 20 and a tibial component 30.
  • the femoral component includes condyles 22 which provide the articulating surface of the femoral component and pegs 24 for affixing the femoral component to the femur.
  • the tibial component 30 includes a tibial base 32 with a peg 34 for mounting the tibial base onto the tibia.
  • a tibial platform 36 is mounted atop the tibial base 32 and is supplied with grooves 38 similar to the shape of the condyles 22.
  • the bottom surfaces of the condyles 26 contact the tibial platform's grooves 38 so that the condyles articulate within these grooves against the tibial platform.
  • the tibial platform may be made from an organic polymer or a polymer-based composite.
  • the hard metallic condyle surfaces 26 would articulate against a relatively softer organic composition. This may result in wear of the organic material, i.e. the tibial platform, necessitating the replacement of the prosthesis.
  • porous bead or wire mesh coatings can also be applied to either the tibial or femoral components of the knee or both.
  • the invention provides uniformly thick zirconium oxide coated orthopedic implants or prostheses fabricated of zirconium or zirconium containing metal alloys or a thin coating of zirconium or zirconium alloy on conventional orthopedic implant materials.
  • the metal alloy should contain from about 80 to about 100 wt% zirconium, preferably from about 95 to about 100 wt%.
  • Oxygen, niobium, and titanium include common alloying elements in the alloy which include often the presence of hafnium.
  • One method of determining if a refined microstructure is present in the zirconium or zirconium alloy is to examine the material in transverse section to examine the secondary phase ( ⁇ ) which should have grains of not larger than about 2 microns wide and with not more than about a 3 micron separation; preferably 1 micron wide and a 2 micron separation.
  • Production of such a fine dispersion of multiple phase grains is not limited to hot forging of barstock and can be accomplished by other processes including, but not limited to, closed die forging, rapid solidification and powder consolidation.
  • the substrate zirconium or zirconium alloy is then subjected to an abrasive surface preparation process that includes, but is not limited to, grinding, buffing, mass finishing and vibratory finishing.
  • the abrasive surface preparation process is used to induce an altered surface roughness (Ra) of from about 3 microinches to about 25 microinches.
  • Ra surface roughness
  • the appropriate altered surface roughness is induced by altering the pre-existing surface roughness to an altered surface roughness of such a magnitude as to permit the formation of a uniform oxide coating when the zirconium or zirconium alloy, each having a refined microstructure and an appropriately altered surface roughness, is subjected to an oxidation process.
  • the substrate is then subjected to process conditions which cause the natural (in situ) formation of a tightly adhered, diffusion-bonded coating of uniformly thick zirconium oxide on its surface.
  • process conditions include, for instance, air, steam, or water oxidation or oxidation in a salt bath.
  • These processes ideally provide a thin, hard, dense, blue-black or black, low-friction wear-resistant uniformly thick zirconium oxide film or coating of thicknesses typically on the order of several microns on the surface of the prosthesis substrate. Below this coating, diffused oxygen from the oxidation process increases the hardness and strength of the underlying substrate metal.
  • the salt-bath method provides a similar, slightly more abrasion resistant blue- black or black zirconium oxide coating. This method requires the presence of an oxidation compound capable of oxidizing zirconium in a molten salt bath.
  • the molten salts include chlorides, nitrates, cyanides, and the like.
  • the oxidation compound sodium carbonate
  • the addition of sodium carbonate lowers the melting point of the salt.
  • the rate of oxidation is proportional to the temperature of the molten salt bath and the
  • the oxidation rate can be different in grains of different structure and composition (such as between alpha and beta grains in a two-phase zirconium alloy).
  • the oxide coating may not grow with a uniform thickness through a microstructure that is too coarse. Specific limits for the necessary minimum surface roughness and maximum microstructural refinement can be alloy and application dependent.
  • the uniformly thick zirconium oxide coating may range up to about 10 microns. It is preferred that a uniformly thick blue-black zirconium oxide layer ranging in thickness from about 1 to about 8 microns should be formed. It is most preferred that the uniformly thick zirconium oxide layer range from about 3 microns to about 7 microns. For example, furnace air oxidation at 1100°F for 3 hours will form a uniform oxide coating of a thickness of 4-5 microns on ZIRCADYNE 705 with a surface roughness (Ra) of about 4 microinches. Longer oxidation times and higher oxidation temperatures will increase this thickness, but may compromise coating integrity.
  • one hour at 1300°F will form an oxide coating about 14 microns in thickness, while 21 hours at 1000°F will form an oxide coating thickness of about 9 microns.
  • oxide coating thickness of about 9 microns.
  • Blue-black zirconium oxide coatings produced by any of the prior art methods are quite similar in hardness. For example, if the surface of a wrought ZIRCADYNE
  • the surface hardness of the blue-black zirconium oxide surface following oxidation by either the salt bath or air oxidation process is approximately 1200-1700 Knoop hardness.
  • These diffusion-bonded, low friction, highly wear resistant, uniformly thick zirconium oxide coatings can be applied to the surfaces of orthopedic implants subject to conditions of wear and to prosthetic implants and devices requiring a biocompatible surface.
  • Such surfaces include the articulating surfaces of knee joints, elbows and hip joints.
  • the femoral head and stem are typically fabricated of metal alloys while the acetabular cup may be fabricated from ceramics, metals or organic polymer-lined metals or ceramics.
  • the oxide coating surface can be polished by any of a variety of conventional finishing techniques. Sufficient oxide thickness must be produced to accommodate the chosen finishing technique. For example, a surface with a uniform oxide coating of about 5 microns thick that had a pre-oxidation surface roughness (Ra) of about 4 microinches can be burnished to a final surface roughness (Ra) of about 2 microinches with a loss of about 1 micron in oxide thickness.
  • Zirconium or zirconium alloy can also be used to provide a porous bead or wire mesh surface to which surrounding bone or other tissue may integrate to stabilize the prosthesis. These porous coatings can be treated simultaneously by the oxidation of the base prosthesis for the elimination or reduction of metal ion release. Furthermore, zirconium or zirconium alloy can also be used as a surface layer applied over conventional implant materials prior to inducing an altered surface roughness, in situ oxidation and formation of the uniform zirconium oxide coating.
  • the process of the present invention avoids the problems of formation of thick oxide coatings of low abrasion resistance and of significant dimensional changes of the process in U.S. Patent 3,615,885.
  • the present invention also produces an oxide film that is highly abrasion resistant, unlike that of the '885 patent.
  • the process of the present invention by inducing an altered surface roughness on zirconium or a zirconium alloy, each having a refined microstructure, results in the formation of a blue-black zirconium dioxide coating of uniform thickness, the depth of which can be controlled by the proper choice of the oxidation conditions.
  • the formation of a uniformly thick oxide coating provides an oxide coating of variable and controlled thickness with especially high abrasion resistance and reduced wear due to high integrity of the adhesion between the oxide layer and the underlying zirconium or zirconium alloy and the high integrity of the adhesion within the oxide layer.
  • high integrity denotes an oxide coating that is uniform in thickness with no visible cracks or pores when viewed in cross-section by optical microscopy.
  • the invention provides a zirconium or zirconium-containing metal alloy prosthesis with a refined microstructure coated via in situ oxidation with a zirconium oxide of uniform thickness.
  • the uniformly thick zirconium oxide coating provides the invention prosthesis with a thin, dense, low friction, high integrity, wear resistant, biocompatible surface ideally suited for use on articulating surfaces of joint prostheses wherein a surface or surfaces of the joint articulates, translates or rotates against mating joint surfaces.
  • the uniformly thick zirconium oxide coating may therefore be usefully employed on the femoral heads or inside surfaces of acetabular cups of hip-joint implants or on the articulating surfaces of other types of prostheses, such as knee joints.
  • the uniformly thick zirconium oxide coating serve to improve the protection of the prosthesis substrate to which it is applied due to its high integrity, it also, as a result of its low friction surface, protects those surfaces against which it is in operable contact and consequently enhances the performance and life of the prosthesis.
  • a uniformly thick zirconium oxide coated joint surface also enhances the useful life of the opposing surface when the opposing surface is body tissue.
  • the surgical replacement of one component of the joint is termed “hemiarthroplasty” and because the repaired joint has only one artificial (prosthesis) component, the artificial component is often termed a "unipolar" prosthesis, or "endoprosthesis.”
  • the uniformly thick zirconium oxide coating is a low friction surface for articulation, translation and rotation against body tissue thereby having the same beneficial effect for a body tissue counterface as it does for an organic polymer counterface.
  • the usefulness of zirconium oxide coated prosthesis is not limited to load bearing prostheses, especially joints, where a high rate of wear may be encountered.
  • the uniformly thick zirconium oxide coating is especially firmly bonded to the zirconium alloy prosthesis substrate, it provides an enhanced barrier between the body fluids and the zirconium alloy metal thereby preventing the corrosion of the alloy by the process of ionization and its associated metal ion release compared to non-uniform oxide coatings.
  • the natural in situ formation of a uniformly thick zirconium oxide coating from the presence of zirconium in the substrate metal involves oxygen diffusion into the metal substrate below the oxide coating.
  • Oxygen an alloying constituent in zirconium, increases the strength of the metal substrate, particularly the fatigue strength.
  • the high integrity of the uniformly thick coating reduces the number of fatigue crack initiation sites relative to a non-uniformly thick oxide coating that contains cracks or pores. Resistance to fatigue loading is paramount in many orthopedic implant applications such as the hip stem, and femoral and tibial knee components.
  • the formation of the uniformly thick zirconium oxide coating improve wear, friction, and corrosion resistance, it also improves the mechanical integrity of the implant device from a strength standpoint.

Abstract

An oxide coating is formed on zirconium or zirconium alloys of refined microstructure by a process comprising at least the step of inducing an appropriate altered surface roughness such that subsequent oxidation results in a uniformly thick oxide coating. An oxide coating of uniform and controlled thickness is especially useful on orthopedic implants of zirconium or zirconium-based alloys to provide low friction, highly wear resistant surfaces on artificial joints, such as hip joints, knee joints, elbows, etc. The uniformly thick oxide coating of controlled depth on oxide coated prostheses provides a barrier against implant corrosion caused by ionization of the metal prosthesis.

Description

METHOD OF SURFACE OXIDIZING ZIRCONIUM ALLOYS AND RESULTING PRODUCT
This invention relates to metallic orthopedic implants with load bearing surfaces coated with a thin, dense, low friction, highly wear-resistant, uniformly thick coating of zirconium oxide.
The invention also relates to uniformly thick zirconium oxide coatings on the non-load bearing surfaces of an orthopedic implant where the zirconium oxide provides a barrier between the metallic prosthesis and body tissue thereby preventing the release of metal ions and corrosion of the implant.
The invention also relates to a method of producing a uniformly thick oxide coating on zirconium or a zirconium alloy by controlling the surface roughness of the zirconium or zirconium alloy having a refined microstructure prior to formation of the oxide coating. The excellent corrosion resistance of zirconium has been known for many years. Zirconium displays excellent corrosion resistance in many aqueous and non- aqueous media and for this reason has seen an increased use in the chemical process industry and in medical applications. A limitation to the wider application of zirconium in these areas is its relatively low resistance to abrasion and its tendency to gall. This relatively low resistance to abrasion and the tendency to gall is also demonstrated in zirconium alloys.
Orthopedic implant materials must combine high strength, corrosion resistance and tissue compatibility. The longevity of the implant is of prime importance especially if the recipient of the implant is relatively young because it is desirable that the implant function for the complete lifetime of a patient. Because certain metal alloys have the required mechanical strength and biocompatibility, they are ideal candidates for the fabrication of prostheses. These alloys include 316L stainless steel, chrome-cobalt-molybdenum alloys and, more recently, titanium alloys which have proven to be the most suitable materials for the fabrication of load-bearing prostheses. One of the variables affecting the longevity of load-bearing implants, such as hip joint implants, is the rate of wear of the articulating surfaces and long-term effects of the metal ion release. A typical hip joint prosthesis includes a stem, a femoral head and an acetabular cup against which the femoral head articulates. Wear of either or both of the articulating surfaces results in an increasing level of wear particulates and "play" between the femoral head and the cup against which it articulates. Wear debris can contribute to adverse tissue rejection leading to bone resorption, and ultimately the joint must be replaced. The rate of wear is dependent upon a number of factors which include the relative hardness and surface finish of the material which constitute the femoral head and the acetabular cup, the frictional coefficient between the materials of the cup and head, the load applied and the stresses generated at the articulating surface. The most common material combinations currently used in fabrication of hip joints implants include femoral heads of cobalt or titanium alloys articulating against acetabular cups lined with organic polymers or composites of such polymers including, e.g., ultra high molecular weight polyethylene (UHMWPE), and femoral heads of polished alumina in combination with acetabular cups lined with an organic polymer or composite or cups made of polished alumina. Of the factors that influence the rate of wear of conventional hip-joint implants, the most significant are patient weight and activity level. Additionally, heat which is generated by friction in the normal use of the implant as, for instance, in walking has been shown to cause accelerated creep and wear of the polyethylene cup. Furthermore, there is a correlation between the frictional moment which transfers torque loading to the cup and the frictional coefficient between the femoral head and the surface of the acetabular cup against which the head articulates. Cup torque has been associated with cup loosening. Thus, in general, the higher the coefficient of friction for a given load, the higher the level of torque generated. Ceramic bearing surfaces have been shown to produce significantly lower levels of frictional torque. It is also noteworthy that two of the three commonly used hip-joint systems as indicated above include a metallic femoral head articulating against a UHMWPE liner inside the acetabular cup. UHMWPE, being a polymeric material, is more susceptible to creep when heated than the commonly used metal alloys or ceramics and is consequently more susceptible to wear than the alloys or ceramics. It has also been found that metal prostheses are not completely inert in the body. Body fluids act upon the metals causing them to slowly corrode by an ionizing process that thereby releases metal ions into the body. Metal ion release from the prosthesis is also related to the rate of wear of load bearing surfaces because the passive oxide film, which is formed on the surface, is constantly removed. The repassivation process constantly releases metal ions during the ionizing process. Furthermore, the presence of third-body wear (cement or bone debris) accelerates this process and microfretted metal particles increase friction. Consequently, the
UHMWPE liner inside the acetabular cup, against which the femoral head articulates, is subjected to accelerated levels of creep, wear and torque.
U.S. Patent 415,764 to Suzuki, et al. recognizes that while metal prostheses have excellent mechanical strength they tend to corrode in the body by ionization. Suzuki, et al. also recognized the affinity between ceramics and bone tissue but noted that ceramic prostheses are weak on impact resistance. Suzuki, et al. therefore proposed metal prosthesis plasma sprayed with a bonding agent which is in turn covered with a porous cement coating which will allow the ingrowth of bone spincules into the pores. This combination, it was said, would provide both the mechanical strength of metals and the bio-compatibility of ceramics.
The Suzuki patent did not address the issue of friction or wear of orthopedic implant bearing surfaces but confined itself to the single issue of the biocompatibility of metal prostheses. Furthermore, Suzuki et al. did not address the issue of dimensional changes that occur when applying a coating or the effect of these dimensional changes in the tightness of fit between the surfaces of an articulating joint prosthesis.
In addition, the application of ceramic coating to metal substrates often results in non-uniform, poorly adhering coatings which tend to crack due to the differences in elastic modulus or thermal expansion between the ceramic and underlying metal substrate. Furthermore, such coatings tend to be relatively thick (50-300 microns) and since the bond between the metal and the ceramic coating is often weak, there is the risk of galling or separation of ceramic coatings.
Previous attempts have been made to produce zirconium oxide coatings on zirconium parts for the purpose of increasing their abrasion resistance. One such process is disclosed in U.S. Patent No. 3,615,885 to Watson which discloses a procedure for developing thick (up to 0.23 mm) oxide layers on Zircaloy 2 and Zircaloy 4. However, this procedure results in significant dimensional changes especially for parts having a thickness below about 5 mm, and the oxide film produced does not exhibit especially high abrasion resistance.
U.S. Patent No. 2,987,352 to Watson discloses a method of producing a blue- black oxide coating on zirconium alloy parts for the purpose of increasing their abrasion resistance. Both U.S. Patent 2,987,352 and U.S. Patent 3,615,885 produce a zirconium dioxide coating on zirconium alloy by means of air oxidation. U.S. Patent 3,615,885 continues the air oxidation long enough to produce a beige coating of greater thickness than the blue-black coating of U.S. Patent No. 2,987,352. This beige coating does not have the wear resistance of the blue-black coating and is thus not applicable to many parts where there are two work faces in close proximity. The beige coating wears down more quickly than the blue-black oxide coating with the resulting formation of zirconium oxide particles and the loss of the integrity of the zirconium oxide surface. With the loss of the oxide surface the zirconium metal is then exposed to its environment and can lead to transport of zirconium ions away from the surface of the metal into the adjacent environment.
The blue-black oxide coatings have a thickness which is less than that of the beige coating although the hardness of the blue-black coating is higher than that of the beige coating. This harder blue-black oxide coating lends itself better to surfaces such as prosthetic devices. Although the blue-black coating is more abrasion resistant than the beige coating it is a relatively thin coating. It is therefore desirable to produce the blue-black coatings of increased abrasion resistance without producing the same type coatings of the prior art.
U.S. Patent 5,037,438 to Davidson discloses a method of producing zirconium alloy prostheses with a zirconium oxide surface. U.S. Patent 2,987,352 to Watson discloses a method of producing zirconium bearings with a zirconium oxide surface.
The oxide coating produced is not always uniform in thickness and the non- uniformity reduces the integrity of the bonding between the zirconium alloy and the oxide layer and the integrity of the bonding within the oxide layer.
There exists a need for a method to produce oxide coatings of uniform thickness on zirconium alloys. There exists a need for a metal alloy based orthopedic implant having low friction and highly wear resistant load bearing surfaces that can be implanted for the lifetime of the recipient. There also exists a need for a metal alloy based orthopedic implant that is not prone to corrosion by the action of the body fluids and is biocompatible and stable over the lifetime of the recipient.
The invention provides a method for forming a uniformly thick oxide coating on zirconium or a zirconium alloy, each having a refined microstructure, by inducing an altered surface roughness on the zirconium or zirconium alloy, prior to oxidizing the zirconium or zirconium alloy to form a blue-black zirconium oxide coating of uniform and controlled thickness. The invention also provides a method for forming a uniformly thick oxide coating on a zirconium or zirconium alloy prosthesis, for implantation in a patient, by inducing an altered surface roughness on at least a portion of the zirconium or zirconium alloy prosthesis, wherein the zirconium or zirconium oxide has a refined microstructure, prior to oxidizing the prosthesis to form a blue-black zirconium oxide coating of uniform and controlled thickness on at least a portion of the surface of the prosthesis.
Figure 1 is a schematic diagram depicting a hip joint prosthesis in position. Figure 2 is a schematic diagram showing a typical hip joint prosthesis.
Figure 3 is a schematic diagram of a knee joint prosthesis in place. Figure 4 is a schematic diagram of the parts of a typical knee joint. One aspect of the present invention is to provide a method for forming an oxide coating of uniform thickness on zirconium or a zirconium alloy, the zirconium or zirconium alloy each having a refined microstructure and an altered surface roughness. Another aspect of the present invention is to provide a low friction, wear resistant oxide coating of uniform thickness on prosthesis surfaces, such as articulating surfaces and irregular surface structures adapted to accommodate tissue ingrowth on a portion of the prosthesis body. The here-claimed method of forming an oxide coating of uniform thickness by inducing an altered surface roughness on zirconium or a zirconium alloy, each having a refined microstructure, prior to oxidizing the zirconium or zirconium alloy is applicable to various prosthetic parts and devices. These prosthetic parts and devices include, but are not limited to, cardiovascular implants including heart valves, total artificial heart implants, ventricular assist devices, vascular grafts and stents; electrical signal carrying devices such as pacemaker and neurological leads, and defibrillator leads; guide wires and catheters; percutaneous devices; and joint prostheses including hip joints or surface replacements, knee joints, shoulder joints, elbows, endoprostheses, spinal segments, and fingers. Illustrative examples of such articulating surfaces are shown in the schematic diagrams, Figures 1-4.
A typical hip joint assembly is shown in situ in Figure 1. The hip joint stem 2 fits into the femur while the femoral head 6 of the prosthesis fits into and articulates against the inner lining 8 of an acetabular cup 10 which in turn is affixed to the pelvis as shown in Figure 1. A porous metal bead or wire mesh coating 12 may be incorporated to allow stabilization of the implant by ingrowth of surrounding tissue into the porous coating. Similarly, such a porous metal bead or wire mesh coating can also be applied to the acetabular component. The femoral head 6 may be an integral part of the hip joint stem 2 or may be a separate component mounted upon a conical taper at the end of the neck 4 of the hip joint prosthesis. This allows the fabrication of a prosthesis having a metallic stem and neck but a femoral head of some other material, such as ceramic. This method of construction is often desirable because ceramics have been found to generate less frictional torque and wear when articulating against the UHMWPE lining of an acetabular cup. Additionally, zirconia ceramic has been shown to produce less wear of the UHMWPE than alumina. Regardless of the materials, however, the femoral head articulates against the inner surface of the acetabular cup thereby causing wear and, in the long term, this may necessitate prosthesis replacement. This is especially the case where the femoral head is of metal and the acetabular cup is lined with an organic polymer or composite thereof. While these polymeric surfaces provide good, relatively low friction surfaces and are biocompatible, they are subject to wear and accelerated creep due to the frictional heat and torque to which they are subjected during ordinary use. A typical knee joint prosthesis is shown in situ in Figure 3. The knee joint includes a femoral component 20 and a tibial component 30. The femoral component includes condyles 22 which provide the articulating surface of the femoral component and pegs 24 for affixing the femoral component to the femur. The tibial component 30 includes a tibial base 32 with a peg 34 for mounting the tibial base onto the tibia. A tibial platform 36 is mounted atop the tibial base 32 and is supplied with grooves 38 similar to the shape of the condyles 22. The bottom surfaces of the condyles 26 contact the tibial platform's grooves 38 so that the condyles articulate within these grooves against the tibial platform. While condyles are typically fabricated of metals, the tibial platform may be made from an organic polymer or a polymer-based composite. Thus, the hard metallic condyle surfaces 26 would articulate against a relatively softer organic composition. This may result in wear of the organic material, i.e. the tibial platform, necessitating the replacement of the prosthesis. As in the case of the hip joint, porous bead or wire mesh coatings can also be applied to either the tibial or femoral components of the knee or both.
The invention provides uniformly thick zirconium oxide coated orthopedic implants or prostheses fabricated of zirconium or zirconium containing metal alloys or a thin coating of zirconium or zirconium alloy on conventional orthopedic implant materials. In order to form continuous and useful zirconium oxide coatings of uniform thickness over the desired surface of the metal alloy prosthesis substrate, the metal alloy should contain from about 80 to about 100 wt% zirconium, preferably from about 95 to about 100 wt%. Oxygen, niobium, and titanium include common alloying elements in the alloy which include often the presence of hafnium. Yttrium may also be alloyed with the zirconium to enhance the formation of a tougher, yttria- stabilized zirconium oxide coating during the oxidation of the alloy. While such zirconium containing alloys may be custom formulated by conventional methods known in the art of metallurgy, a number of suitable alloys are commercially available. These commercial alloys include among others ZIRCADYNE 705,
ZIRCADYNE 702 and Zircalloy.
The base zirconium containing metal alloys are fabricated by conventional methods to the shape and size desired to obtain a prosthesis substrate. The shaped zirconium or zirconium alloy must have a refined microstructure such as might be produced by hot forge conversion of ingot to wrought barstock. Zirconium or a zirconium alloy with a grain size of less than ASTM micro-grain size number 10 would exemplify an acceptable degree of refined microstructure. One method of determining if a refined microstructure is present in the zirconium or zirconium alloy is to examine the material in transverse section to examine the secondary phase (β) which should have grains of not larger than about 2 microns wide and with not more than about a 3 micron separation; preferably 1 micron wide and a 2 micron separation. Production of such a fine dispersion of multiple phase grains is not limited to hot forging of barstock and can be accomplished by other processes including, but not limited to, closed die forging, rapid solidification and powder consolidation.
The substrate zirconium or zirconium alloy is then subjected to an abrasive surface preparation process that includes, but is not limited to, grinding, buffing, mass finishing and vibratory finishing. The abrasive surface preparation process is used to induce an altered surface roughness (Ra) of from about 3 microinches to about 25 microinches. The appropriate altered surface roughness is induced by altering the pre-existing surface roughness to an altered surface roughness of such a magnitude as to permit the formation of a uniform oxide coating when the zirconium or zirconium alloy, each having a refined microstructure and an appropriately altered surface roughness, is subjected to an oxidation process.
The substrate is then subjected to process conditions which cause the natural (in situ) formation of a tightly adhered, diffusion-bonded coating of uniformly thick zirconium oxide on its surface. The process conditions include, for instance, air, steam, or water oxidation or oxidation in a salt bath. These processes ideally provide a thin, hard, dense, blue-black or black, low-friction wear-resistant uniformly thick zirconium oxide film or coating of thicknesses typically on the order of several microns on the surface of the prosthesis substrate. Below this coating, diffused oxygen from the oxidation process increases the hardness and strength of the underlying substrate metal.
The air, steam and water oxidation processes are described in now-expired U.S. Patent 2,987,352 to Watson, the teachings of which are incorporated by reference as though fully set forth. The oxidation process applied to zirconium or a zirconium alloy, each having a refined microstructure and an appropriate degree of altered surface roughness, provides a firmly adherent black or blue-black layer of uniformly thick zirconium oxide of highly oriented monoclinic crystalline form. If the oxidation is continued to excess, the coating will whiten and separate from the metal substrate. For convenience, the metal prosthesis substrate may be placed in a furnace having an oxygen-containing atmosphere (such as air) and typically heated at 900°-1300°F for up to about 6 hours. However, other combinations of temperature and time are possible. When higher temperatures are employed, the oxidation time should be reduced to avoid the formation of the white oxide. One of the salt-bath methods that can be used to apply the zirconium oxide coatings to the metal alloy prosthesis, is the method of U.S. Patent 4,671,824 to Haygarth, the teachings of which are incorporated by reference as though fully set forth. The salt-bath method provides a similar, slightly more abrasion resistant blue- black or black zirconium oxide coating. This method requires the presence of an oxidation compound capable of oxidizing zirconium in a molten salt bath. The molten salts include chlorides, nitrates, cyanides, and the like. The oxidation compound, sodium carbonate, is present in small quantities, up to about 5 wt%. The addition of sodium carbonate lowers the melting point of the salt. As in air oxidation, the rate of oxidation is proportional to the temperature of the molten salt bath and the
'824 patent prefers the range of 550°-800°C (1022°-1470°F). However, the lower oxygen levels in the bath produce thinner coatings than for furnace air oxidation at the same time and temperature. A salt bath treatment at 1290°F for four hours produces an oxide coating thickness of roughly 7 microns. Creation of a uniform oxide coating during the oxidation process, by the here claimed method, is dependent on both a surface with appropriate altered surface roughness and a microstructure with sufficient refinement. The oxide coating initiates and grows from surface asperities, so the oxide initiation sites may be spaced too far apart to produce a uniform coating thickness on a surface that is too smooth. The oxide layer grows by oxygen diffusion along grain boundaries and through microstructural grains. The oxidation rate can be different in grains of different structure and composition (such as between alpha and beta grains in a two-phase zirconium alloy). Thus, the oxide coating may not grow with a uniform thickness through a microstructure that is too coarse. Specific limits for the necessary minimum surface roughness and maximum microstructural refinement can be alloy and application dependent.
The uniformly thick zirconium oxide coating may range up to about 10 microns. It is preferred that a uniformly thick blue-black zirconium oxide layer ranging in thickness from about 1 to about 8 microns should be formed. It is most preferred that the uniformly thick zirconium oxide layer range from about 3 microns to about 7 microns. For example, furnace air oxidation at 1100°F for 3 hours will form a uniform oxide coating of a thickness of 4-5 microns on ZIRCADYNE 705 with a surface roughness (Ra) of about 4 microinches. Longer oxidation times and higher oxidation temperatures will increase this thickness, but may compromise coating integrity. For example, one hour at 1300°F will form an oxide coating about 14 microns in thickness, while 21 hours at 1000°F will form an oxide coating thickness of about 9 microns. Of course, because only a thin oxide is necessary on the surface, only very small dimensional changes, typically less than 10 microns over the thickness of the prosthesis, will result. In general, thinner coatings (1-8 microns) have better attachment strength.
Blue-black zirconium oxide coatings produced by any of the prior art methods are quite similar in hardness. For example, if the surface of a wrought ZIRCADYNE
705 (Zr, 2-3 wt% Nb) prosthesis substrate is oxidized, the hardness of the surface shows a dramatic increase over the 200 Knoop hardness of the original metal surface. The surface hardness of the blue-black zirconium oxide surface following oxidation by either the salt bath or air oxidation process is approximately 1200-1700 Knoop hardness.
These diffusion-bonded, low friction, highly wear resistant, uniformly thick zirconium oxide coatings can be applied to the surfaces of orthopedic implants subject to conditions of wear and to prosthetic implants and devices requiring a biocompatible surface. Such surfaces include the articulating surfaces of knee joints, elbows and hip joints. As mentioned before, in the case of hip joints, the femoral head and stem are typically fabricated of metal alloys while the acetabular cup may be fabricated from ceramics, metals or organic polymer-lined metals or ceramics.
When the zirconium oxide coatings are applied to surfaces subject to wear, it is desirable to obtain a smooth finished surface to minimize abrasive wear. After the oxidation process, the oxide coating surface can be polished by any of a variety of conventional finishing techniques. Sufficient oxide thickness must be produced to accommodate the chosen finishing technique. For example, a surface with a uniform oxide coating of about 5 microns thick that had a pre-oxidation surface roughness (Ra) of about 4 microinches can be burnished to a final surface roughness (Ra) of about 2 microinches with a loss of about 1 micron in oxide thickness.
Zirconium or zirconium alloy can also be used to provide a porous bead or wire mesh surface to which surrounding bone or other tissue may integrate to stabilize the prosthesis. These porous coatings can be treated simultaneously by the oxidation of the base prosthesis for the elimination or reduction of metal ion release. Furthermore, zirconium or zirconium alloy can also be used as a surface layer applied over conventional implant materials prior to inducing an altered surface roughness, in situ oxidation and formation of the uniform zirconium oxide coating.
The process of the present invention avoids the problems of formation of thick oxide coatings of low abrasion resistance and of significant dimensional changes of the process in U.S. Patent 3,615,885. The present invention also produces an oxide film that is highly abrasion resistant, unlike that of the '885 patent. The process of the present invention, by inducing an altered surface roughness on zirconium or a zirconium alloy, each having a refined microstructure, results in the formation of a blue-black zirconium dioxide coating of uniform thickness, the depth of which can be controlled by the proper choice of the oxidation conditions. The formation of a uniformly thick oxide coating provides an oxide coating of variable and controlled thickness with especially high abrasion resistance and reduced wear due to high integrity of the adhesion between the oxide layer and the underlying zirconium or zirconium alloy and the high integrity of the adhesion within the oxide layer. The term "high integrity" denotes an oxide coating that is uniform in thickness with no visible cracks or pores when viewed in cross-section by optical microscopy. The invention provides a zirconium or zirconium-containing metal alloy prosthesis with a refined microstructure coated via in situ oxidation with a zirconium oxide of uniform thickness. The uniformly thick zirconium oxide coating provides the invention prosthesis with a thin, dense, low friction, high integrity, wear resistant, biocompatible surface ideally suited for use on articulating surfaces of joint prostheses wherein a surface or surfaces of the joint articulates, translates or rotates against mating joint surfaces. The uniformly thick zirconium oxide coating may therefore be usefully employed on the femoral heads or inside surfaces of acetabular cups of hip-joint implants or on the articulating surfaces of other types of prostheses, such as knee joints. When a joint surface coated with a uniformly thick zirconium oxide is employed in a manner wherein it articulates or rotates against a non-metallic or non- zirconium oxide coated surface, the low friction characteristic and high integrity of the uniformly thick coating causes reduced friction, wear, and heat generation relative to prior art prostheses. This reduced heat generation results in a lowered tendency for the non-metallic or non-zirconium oxide coating bearing surface to experience creep and torque so that the useful life of the opposing surface is enhanced. Organic polymers, such as UHMWPE, exhibit rapidly increased rates of creep when subjected to heat with consequent deleterious effect on the life span of the liner. Wear debris of the polymer leads to adverse tissue response and loosening of the device. Thus, not only does the uniformly thick zirconium oxide coating serve to improve the protection of the prosthesis substrate to which it is applied due to its high integrity, it also, as a result of its low friction surface, protects those surfaces against which it is in operable contact and consequently enhances the performance and life of the prosthesis.
A uniformly thick zirconium oxide coated joint surface also enhances the useful life of the opposing surface when the opposing surface is body tissue. The surgical replacement of one component of the joint is termed "hemiarthroplasty" and because the repaired joint has only one artificial (prosthesis) component, the artificial component is often termed a "unipolar" prosthesis, or "endoprosthesis." The uniformly thick zirconium oxide coating is a low friction surface for articulation, translation and rotation against body tissue thereby having the same beneficial effect for a body tissue counterface as it does for an organic polymer counterface. The usefulness of zirconium oxide coated prosthesis is not limited to load bearing prostheses, especially joints, where a high rate of wear may be encountered. Because the uniformly thick zirconium oxide coating is especially firmly bonded to the zirconium alloy prosthesis substrate, it provides an enhanced barrier between the body fluids and the zirconium alloy metal thereby preventing the corrosion of the alloy by the process of ionization and its associated metal ion release compared to non-uniform oxide coatings.
Additionally, the natural in situ formation of a uniformly thick zirconium oxide coating from the presence of zirconium in the substrate metal involves oxygen diffusion into the metal substrate below the oxide coating. Oxygen, an alloying constituent in zirconium, increases the strength of the metal substrate, particularly the fatigue strength. Furthermore, the high integrity of the uniformly thick coating reduces the number of fatigue crack initiation sites relative to a non-uniformly thick oxide coating that contains cracks or pores. Resistance to fatigue loading is paramount in many orthopedic implant applications such as the hip stem, and femoral and tibial knee components. Thus, not only does the formation of the uniformly thick zirconium oxide coating improve wear, friction, and corrosion resistance, it also improves the mechanical integrity of the implant device from a strength standpoint.
Although the invention has been described with reference to its preferred embodiments, those of ordinary skill in the art may, upon reading this disclosure, appreciate changes and modifications which may be made and which do not depart from the scope and spirit of the invention as described above or claimed hereafter.

Claims

CLAIMS:
1. A method of producing an oxide coating on zirconium or zirconium alloy, the zirconium or zirconium alloy each having a refined microstructure and a surface roughness, the method comprising: altering said surface roughness of said zirconium or zirconium alloy having a refined microstructure such that an oxidation process applied to said zirconium or zirconium alloy each having a refined microstructure and an altered surface roughness results in the formation of a uniformly thick oxide coating.
2. A method of producing an oxide coating of uniform thickness on zirconium or zirconium alloy, the zirconium or zirconium alloy each having a refined microstructure and a surface roughness, the method comprising: altering said surface roughness such that an altered surface roughness (Ra) is in the range of about 3 microinches to about 25 microinches prior to subjecting said zirconium or zirconium alloy to an oxidation process.
3. The method of claims 1 or 2, wherein an altered surface roughness is induced on the zirconium or zirconium alloy surface by an abrasive surface preparation process comprising a grinding step.
4. The method of claims 1 or 2, wherein said altered surface roughness
(Ra) is in the range of from about 3.5 microinches to about 7 microinches.
5. The method of claims 1 or 2, wherein the zirconium or zirconium alloy has a grain size of less than ASTM micro-grain size number 10.
6. The method of claims 1 or 2, wherein said oxidation process utilizes air as an oxidant.
7. The method of claims 1 or 2, wherein the zirconium or zirconium alloy is produced by a process selected from a group consisting of hot forge conversion of ingot to barstock, closed die forging, rapid solidification and powder consolidation.
8. The method of claims 1 or 2, wherein said altered surface roughness (Ra) is in the range of from about 3.5 microinches to about 7 microinches and the zirconium alloy has a grain size of less than ASTM micro-grain size number 10.
9. The method of claims 1 or 2, wherein altered said surface roughness (Ra) is in the range of from about 3.5 microinches to about 7 microinches and the zirconion or zirconium alloy is produced by a process selected from the group consisting of hot forge conversion of ingot to barstock, closed die forging, rapid solidification and powder consolidation.
10. The method of claims 1 or 2, wherein the uniform oxide coating has a thickness up to about 10 microns.
11. A prosthesis for implantation in a patient, comprising: (a) a prosthesis body formed of zirconium or zirconium alloy comprising an implant portion for inserting into the body tissue of the patient;
(b) a bearing surface comprising at least one condyle on the prosthesis body;
(c) a tibial component formed of an organic polymer or polymer- based composite and adapted to cooperate with the bearing surface; and
(d) a thin coating of blue-black or black zirconium oxide of uniform thickness prepared by the method of claims 1 or 2 directly on the bearing surface of the condyle portion for reducing wear of the organic polymer or polymer- based composite component.
12. The prosthesis of claim 11, wherein said thin blue-black or black zirconium oxide coating is up to about 10 microns thick.
13. The prosthesis of claim 12, wherein the implant portion of the prosthesis body further comprises an irregular surface structure adapted to accommodate tissue ingrowth on a portion of the prosthesis body.
14. The prosthesis of claim 13, wherein the irregular surface structure is formed of zirconium or zirconium alloy beads attached to the outer surface of the prosthesis body, wherein at least a portion of the surface of the beads is oxidized to blue-black or black zirconium oxide of uniform thickness by the method of claims 1 or 2.
15. The prosthesis of claim 13, wherein the irregular surface structure is formed of zirconium or zirconium alloy wire mesh connected to the outer surface of the prosthesis body, wherein at least a portion of the surface of the mesh is oxidized to blue-black or black zirconium oxide of uniform thickness by the method of claims 1 or 2.
16. A prosthesis for implantation in a patient, comprising: (a) a hip prosthesis body for implantation into a femor comprising a head potion formed of zirconium or zirconium alloy;
(b) a bearing surface on the head portion of the prosthesis body;
(c) an acetabular cup having an inner surface formed of an organic polymer or a polymer-based composite, said inner surface being adapted to cooperate with the bearing surface on the head portion; and
(d) a thin coating of blue-black or black zirconium oxide of uniform thickness prepared by the method of claims 1 or 2 directly on the bearing surface of the head portion for reducing wear of the acetabular cup inner surface.
17. The prosthesis of claim 16, wherein said thin blue-black or black zirconium oxide coating of uniform thickness is up to about 10 microns thick.
18. The prosthesis of claim 16, wherein the prosthesis body further comprises an irregular surface structure adapted to accommodate tissue ingrowth on a portion of the prosthesis body.
19. The prosthesis of claim 18, wherein the irregular surface structure is formed of zirconium or zirconium alloy beads connected to the outer surface of the prosthesis body, wherein at least a portion of the surface of the beads is oxidized to blue-black or black zirconium oxide of uniform thickness by the method of claims 1 or 2.
20. The prosthesis of claim 18, wherein the irregular surface structure is formed of zirconium or zirconium alloy wire mesh connected to the outer surface of the prosthesis body, wherein at least a portion of the surface of the mesh is oxidized to blue-black or black zirconium oxide of uniform thickness by the method of claims 1 or 2.
21. A prosthesis for implantation in a patient, comprising: (a) a prosthesis body formed of zirconium or zirconium alloy comprising an implant portion for insertion into the body tissue of the patient;
(b) a bearing surface on the prosthesis body, the bearing surface being sized and shaped to engage or cooperate with a second bearing surface on another prosthesis portion, said second bearing surface being formed of an organic polymer or polymer-based composite; and
(c) a coating, formed by the method of claims 1 or 2, of blue-black or black zirconium oxide of uniform thickness up to about 10 microns in thickness on the bearing surface of the prosthesis body for reducing wear on the organic polymer or polymer-based second bearing surface of said another prosthesis portion.
22. The prosthesis of claim 21, wherein the prosthesis body is a hip joint having a head portion as a bearing surface and wherein said another prosthesis portion is an acetabular cup, said head portion being adapted to cooperate with the inner surface of the acetabular cup, said inner surface comprising an organic polymer or polymer-based composite.
23. The prosthesis of claim 21, wherein the prosthesis body is a knee joint and the bearing surface of the prosthesis body comprises at least one condyle, and wherein said another prosthesis portion comprises a tibial component formed of an organic polymer or polymer-based composite, said at least one condyle being adapted to cooperate with the tibial component.
24. The prosthesis of claim 21, wherein the prosthesis body further comprises an irregular surface structure adapted to accommodate tissue ingrowth on a portion of the prosthesis body.
25. The prosthesis of claim 24, wherein the irregular surface structure is formed of zirconium or zirconium alloy beads connected to the outer surface of the prosthesis body, wherein at least a portion of the surface of the beads is oxidized to blue-black or black zirconium oxide of uniform thickness by the method of claims 1 or 2.
26. The prosthesis of claim 24, wherein the irregular surface structure is formed of zirconium or zirconium alloy wire mesh connected to the outer surface of the prosthesis body, wherein at least a portion of the surface of the mesh is oxidized to blue-black or black zirconium oxide of uniform thickness by the method of claims 1 or 2.
27. A prosthesis for implantation in a patient, comprising:
(a) a prosthesis body formed of zirconium or zirconium alloy comprising an implant portion for inserting into the body tissue of the patient;
(b) a bearing surface on the prosthesis body; (c) a counter-bearing surface formed of an organic polymer or polymer-based composite and adapted to cooperate with the bearing surface; and (d) a thin coating of blue-black or black zirconium oxide of uniform thickness prepared by the method of claims 1 or 2 directly on the bearing surface for reducing wear of the organic polymer or polymer-based composite counter-bearing surface.
28. The prosthesis of claim 27, wherein said thin blue-black or black zirconium oxide coating of uniform thickness is up to about 10 microns thick by the method of claims 1 or 2.
29. The prosthesis of claim 28, wherein the implant portion of the prosthesis body further comprises an irregular surface structure adapted to accommodate tissue ingrowth on a portion of the prosthesis body.
30. The prosthesis of claim 29, wherein the irregular surface structure is formed of zirconium or zirconium alloy beads attached to the outer surface of the prosthesis body, wherein at least a portion of the surface of the beads is oxidized to blue-black or black zirconium oxide of uniform thickness by the method of claims 1 or 2.
31. The prosthesis of claim 29, wherein the irregular surface structure is formed of zirconium or zirconium ally wire mesh connected to the outer surface of the prosthesis body, wherein at least a portion of the surface of the mesh is oxidized to blue-black or black zirconium oxide of uniform thickness by the method of claims 1 or 2.
32. The prosthesis body of claims 11, 16, 21 or 27 wherein the zirconium or zirconium alloy is wrought barstock.
33. A prosthesis for implantation in a patient, comprising: (a) a prosthesis body having an external surface at least a portion of which is formed of zirconium or zirconium alloy, each having a refined microstructure and an altered surface roughness; and
(b) a zirconium oxide coating of uniform thickness formed on said portion i of the external surface by inducing an altered surface roughness on at least said portion of the external surface and subjecting said portion of the external surface of said prosthesis body to an oxidation process.
34. The prosthesis of claim 33 wherein the prosthesis body is an endoprothesis body suitable for use in a joint selected from a group consisting of knee joint, hip joint and shoulder joint.
35. The prosthesis of claims 11, 16, 21, 27, 33 or 34, wherein the zirconium or zirconium alloy is formed by a process selected from a group consisting of hot forge conversion of ingot to barstock, closed die forging, rapid solidification and powder consolidation.
PCT/US1998/006059 1997-03-27 1998-03-27 Method of surface oxidizing zirconium alloys and resulting product WO1998042390A1 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
DE69825570T DE69825570T2 (en) 1997-03-27 1998-03-27 METHOD FOR THE PRODUCTION OF OXIDES WITH CONSTANT THICKNESS ON CIRCONIUM ALLOYS
AT98912091T ATE273036T1 (en) 1997-03-27 1998-03-27 METHOD FOR PRODUCING CONSTANT THICKNESS OXIDES ON ZIRCONIUM ALLOYS
JP54601598A JP4491076B2 (en) 1997-03-27 1998-03-27 Zirconium alloy surface oxidation method and product by this method
US09/381,217 US6447550B1 (en) 1997-03-27 1998-03-27 Method of surface oxidizing zirconium alloys and resulting product
AU65889/98A AU736216B2 (en) 1997-03-27 1998-03-27 Method of surface oxidizing zirconium alloys and resulting product
EP98912091A EP0968011B1 (en) 1997-03-27 1998-03-27 Method of surface oxidizing zirconium alloys and resulting product
CA002284816A CA2284816C (en) 1997-03-27 1998-03-27 Method of surface oxidizing zirconium alloys and resulting product
US09/909,612 US6585772B2 (en) 1997-03-27 2001-07-20 Method of surface oxidizing zirconium and zirconium alloys and resulting product
US10/382,228 US7070623B2 (en) 1997-03-27 2003-03-05 Method of surface oxidizing zirconium and zirconium alloys and resulting product
US11/431,764 US7582117B2 (en) 1997-03-27 2006-05-10 Method of surface oxidizing zirconium and zirconium alloys and resulting product

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4236497P 1997-03-27 1997-03-27
US60/042,364 1997-03-27

Related Child Applications (5)

Application Number Title Priority Date Filing Date
US09381217 A-371-Of-International 1998-03-27
US09/381,217 Continuation-In-Part US6447550B1 (en) 1997-03-27 1998-03-27 Method of surface oxidizing zirconium alloys and resulting product
US09/381,217 A-371-Of-International US6447550B1 (en) 1997-03-27 1998-03-27 Method of surface oxidizing zirconium alloys and resulting product
US09/909,612 Continuation-In-Part US6585772B2 (en) 1997-03-27 2001-07-20 Method of surface oxidizing zirconium and zirconium alloys and resulting product
US09/909,612 Continuation US6585772B2 (en) 1997-03-27 2001-07-20 Method of surface oxidizing zirconium and zirconium alloys and resulting product

Publications (1)

Publication Number Publication Date
WO1998042390A1 true WO1998042390A1 (en) 1998-10-01

Family

ID=21921500

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/006059 WO1998042390A1 (en) 1997-03-27 1998-03-27 Method of surface oxidizing zirconium alloys and resulting product

Country Status (11)

Country Link
US (2) US6447550B1 (en)
EP (1) EP0968011B1 (en)
JP (2) JP4491076B2 (en)
AT (1) ATE273036T1 (en)
AU (1) AU736216B2 (en)
CA (1) CA2284816C (en)
DE (1) DE69825570T2 (en)
DK (1) DK0968011T3 (en)
ES (1) ES2227818T3 (en)
PT (1) PT968011E (en)
WO (1) WO1998042390A1 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002098473A1 (en) * 2001-06-01 2002-12-12 Smith & Nephew, Inc. Prostheses devices employing oxidized zirconium contacting surfaces
WO2003008657A1 (en) * 2001-07-20 2003-01-30 Smith & Newphew, Inc. Method of surface oxidizing zirconium and zirconium alloys and resulting product
WO2003008008A1 (en) * 2001-07-18 2003-01-30 Smith & Nephew, Inc. Prosthetic devices employing oxidized zirconium surfaces contacting surfaces of cross-linked polyethylene
WO2003049781A1 (en) 2001-12-06 2003-06-19 Smith & Nephew, Inc. In-situ oxidized textured surfaces for prosthetic devices and method of making same
WO2004002543A1 (en) * 2002-06-27 2004-01-08 Smith & Nephew Inc. Prosthetic devices having diffusion-hardened surfaces and bioceramic coatings
EP1433443A1 (en) * 2002-12-27 2004-06-30 Biomet Merck Limited Hip prosthesis with ceramic bearing
US7182784B2 (en) 2001-07-18 2007-02-27 Smith & Nephew, Inc. Prosthetic devices employing oxidized zirconium and other abrasion resistant surfaces contacting surfaces of cross-linked polyethylene
US7582117B2 (en) 1997-03-27 2009-09-01 Smith & Nephew Inc. Method of surface oxidizing zirconium and zirconium alloys and resulting product
EP2759280A1 (en) 2013-01-25 2014-07-30 McMinn, Derek James Wallace Prosthesis Having a Large Femoral Head
US9764061B2 (en) 2004-09-16 2017-09-19 Smith & Nephew, Inc. Method of providing a zirconium surface and resulting product
US10004604B2 (en) 2006-09-08 2018-06-26 Kyocera Corporation Bioimplant for artifical joint with evanescent coating film
US10610614B2 (en) 2006-09-08 2020-04-07 Kyocera Corporation Bioimplant with evanescent coating film
EP3936634A4 (en) * 2019-03-07 2022-01-12 Suzhou Microport Orthorecon Co., Ltd. Preparation method and application of oxidized ceramic layer on surface of zirconium and zirconium alloy
US11278642B2 (en) 2006-09-08 2022-03-22 Takao Hotokebuchi Bioimplant with evanescent coating film

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261322B1 (en) 1998-05-14 2001-07-17 Hayes Medical, Inc. Implant with composite coating
US6827742B2 (en) * 1998-05-14 2004-12-07 Daniel E. E. Hayes, Jr. Bimetal acetabular component construct for hip joint prosthesis
SE514323C2 (en) * 1999-05-31 2001-02-12 Nobel Biocare Ab Implants and procedure and use in implants
WO2002007651A1 (en) 2000-07-20 2002-01-31 Hayes Medical, Inc. Bimetal tibial component construct for knee joint prosthesis
US7402173B2 (en) * 2000-09-18 2008-07-22 Boston Scientific Scimed, Inc. Metal stent with surface layer of noble metal oxide and method of fabrication
US7101391B2 (en) * 2000-09-18 2006-09-05 Inflow Dynamics Inc. Primarily niobium stent
US8123814B2 (en) 2001-02-23 2012-02-28 Biomet Manufacturing Corp. Method and appartus for acetabular reconstruction
US7597715B2 (en) 2005-04-21 2009-10-06 Biomet Manufacturing Corp. Method and apparatus for use of porous implants
SE519566C2 (en) * 2001-07-04 2003-03-11 Nobel Biocare Ab Method of Treating Implants by Coating with Calcium Phosphate and Bone Growth Stimulants
US20040034432A1 (en) * 2002-02-11 2004-02-19 Dean Hughes Mobile bearing tibial base prosthetic devices employing oxidized zirconium surfaces
US20030153979A1 (en) * 2002-02-11 2003-08-14 Dean Hughes Posterior stabilized knee system prosthetic devices employing diffusion-hardened surfaces
US9155544B2 (en) 2002-03-20 2015-10-13 P Tech, Llc Robotic systems and methods
AU2003258298A1 (en) 2002-08-19 2004-03-03 Liquidmetal Technologies Medical implants
WO2004050930A2 (en) 2002-12-04 2004-06-17 California Institute Of Technology BULK AMORPHOUS REFRACTORY GLASSES BASED ON THE Ni-(-Cu-)-Ti(-Zr)-A1 ALLOY SYSTEM
US20050025804A1 (en) * 2003-07-28 2005-02-03 Adam Heller Reduction of adverse inflammation
IL158633A0 (en) * 2003-10-28 2004-05-12 Yaacov Bar Ziv Cartilage-preserving long bone head prosthesis
US20050101953A1 (en) * 2003-11-10 2005-05-12 Simonson Peter M. Artificial facet joint and method
US7083622B2 (en) * 2003-11-10 2006-08-01 Simonson Peter M Artificial facet joint and method
US6974625B2 (en) * 2003-12-16 2005-12-13 Smith & Nephew, Inc. Oxidized zirconium on a porous structure for bone implant use
US20050171604A1 (en) * 2004-01-20 2005-08-04 Alexander Michalow Unicondylar knee implant
US20060052880A1 (en) * 2004-09-09 2006-03-09 Smith & Nephew, Inc. Plasma sprayed porous coating for medical implants
US8292967B2 (en) 2005-04-21 2012-10-23 Biomet Manufacturing Corp. Method and apparatus for use of porous implants
US8066778B2 (en) 2005-04-21 2011-11-29 Biomet Manufacturing Corp. Porous metal cup with cobalt bearing surface
US8266780B2 (en) 2005-04-21 2012-09-18 Biomet Manufacturing Corp. Method and apparatus for use of porous implants
US8021432B2 (en) 2005-12-05 2011-09-20 Biomet Manufacturing Corp. Apparatus for use of porous implants
CN104352290B (en) * 2005-12-15 2020-02-21 史密夫和内修有限公司 Diffusion hardened medical implant
US8795441B2 (en) * 2006-04-26 2014-08-05 Smith & Nephew, Inc. Reworking of surface oxidized and nitrided components
NL1032851C2 (en) * 2006-11-10 2008-05-14 Fondel Finance B V Kit and method for fixing a prosthesis or part thereof and / or filling bony defects.
US8163028B2 (en) 2007-01-10 2012-04-24 Biomet Manufacturing Corp. Knee joint prosthesis system and method for implantation
US8187280B2 (en) 2007-10-10 2012-05-29 Biomet Manufacturing Corp. Knee joint prosthesis system and method for implantation
US8562616B2 (en) 2007-10-10 2013-10-22 Biomet Manufacturing, Llc Knee joint prosthesis system and method for implantation
EP2104474B1 (en) 2007-01-10 2012-08-29 Biomet Manufacturing Corp. Knee joint prosthesis system
US8328873B2 (en) 2007-01-10 2012-12-11 Biomet Manufacturing Corp. Knee joint prosthesis system and method for implantation
US7771775B2 (en) * 2007-03-26 2010-08-10 Howmedica Osteonics Corp. Method for fabricating a medical component from a material having a high carbide phase
US8057914B2 (en) * 2007-03-26 2011-11-15 Howmedica Osteonics Corp. Method for fabricating a medical component from a material having a high carbide phase and such medical component
US8920534B2 (en) 2007-03-26 2014-12-30 Howmedica Osteonics Corp. Method for fabricating a biocompatible material having a high carbide phase and such material
US7833274B2 (en) * 2007-05-16 2010-11-16 Zimmer, Inc. Knee system and method of making same
US8066770B2 (en) * 2007-05-31 2011-11-29 Depuy Products, Inc. Sintered coatings for implantable prostheses
CA2690303C (en) * 2007-06-11 2016-10-18 Smith & Nephew, Inc. Ceramic layered medical implant
US8790345B2 (en) * 2007-08-21 2014-07-29 Zimmer, Inc. Titanium alloy with oxidized zirconium for a prosthetic implant
CA2610634C (en) * 2007-11-16 2012-01-03 Gad Zak A method for creating metal articles with strengthened hardened and darkened surface to desirable degrees, and the articles made by it
US8361381B2 (en) 2008-09-25 2013-01-29 Smith & Nephew, Inc. Medical implants having a porous coated surface
GB0818156D0 (en) * 2008-10-03 2008-11-12 Smith & Nephew Orthopaedics Ag Plasma spray process and products formed thereby
US8123815B2 (en) 2008-11-24 2012-02-28 Biomet Manufacturing Corp. Multiple bearing acetabular prosthesis
GB0905009D0 (en) 2009-03-24 2009-05-06 Stanmore Implants Worldwide Ltd Percutaneous device
US8454707B2 (en) * 2009-04-03 2013-06-04 University Of Maryland Biomedical implantable material and methods of producing the same
US8308810B2 (en) 2009-07-14 2012-11-13 Biomet Manufacturing Corp. Multiple bearing acetabular prosthesis
US8142511B2 (en) 2010-04-19 2012-03-27 Zimmer, Inc. Bi-material prosthesis component
US20110270021A1 (en) * 2010-04-30 2011-11-03 Allergan, Inc. Electronically enhanced access port for a fluid filled implant
US8727203B2 (en) 2010-09-16 2014-05-20 Howmedica Osteonics Corp. Methods for manufacturing porous orthopaedic implants
US9248020B2 (en) * 2010-11-17 2016-02-02 Zimmer, Inc. Ceramic monoblock implants with osseointegration fixation surfaces
US9023112B2 (en) * 2011-02-24 2015-05-05 Depuy (Ireland) Maintaining proper mechanics THA
US9668745B2 (en) 2011-12-19 2017-06-06 Depuy Ireland Unlimited Company Anatomical concentric spheres THA
US8858645B2 (en) 2012-06-21 2014-10-14 DePuy Synthes Products, LLC Constrained mobile bearing hip assembly
US10066276B2 (en) 2012-06-25 2018-09-04 Crucible Intellectual Property, Llc High thermal stability bulk metallic glass in the Zr—Nb—Cu—Ni—Al system
US9763791B2 (en) 2013-02-06 2017-09-19 Howmedica Osteonics Corp. Femoral prosthesis head
US9949837B2 (en) 2013-03-07 2018-04-24 Howmedica Osteonics Corp. Partially porous bone implant keel
US20150366668A1 (en) * 2014-06-23 2015-12-24 Community Blood Center Cellular-scale surface modification for increased osteogenic protein expression
US10280494B2 (en) 2014-07-30 2019-05-07 Apple Inc. Zirconium (Zr) and Hafnium (Hf) based BMG alloys
JP6652133B2 (en) 2015-05-29 2020-02-19 株式会社Gsユアサ Lead storage battery and method of manufacturing lead storage battery
US10058393B2 (en) 2015-10-21 2018-08-28 P Tech, Llc Systems and methods for navigation and visualization
EP4106679A1 (en) 2020-02-19 2022-12-28 DePuy Synthes Products, Inc. Coated implant and method of making the same
JP2023514373A (en) 2020-02-19 2023-04-05 デピュイ・シンセス・プロダクツ・インコーポレイテッド Coated implant and method of making same
US20230096615A1 (en) 2020-02-19 2023-03-30 DePuy Synthes Products, Inc. Metallic orthopaedic implant and method of making the same
US20230323519A1 (en) * 2022-04-11 2023-10-12 Michael T. Clarke Formation of surface oxide coatings for zirconium and zirconium based alloys

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037438A (en) * 1989-07-25 1991-08-06 Richards Medical Company Zirconium oxide coated prosthesis for wear and corrosion resistance
EP0555038A1 (en) * 1992-02-04 1993-08-11 SMITH & NEPHEW RICHARDS, INC. Zirconium oxide and nitride coated cardiovascular implants
WO1994002083A1 (en) * 1992-07-27 1994-02-03 Smith & Nephew Richards Inc. Artificial heart components with improved biocompatible coating
EP0608997A1 (en) * 1993-01-19 1994-08-03 SMITH & NEPHEW RICHARDS, INC. Endoprostheses for tissue protection

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2987352A (en) 1958-02-10 1961-06-06 Ca Atomic Energy Ltd Zirconium bearings and process of producing same
US3615885A (en) 1966-09-19 1971-10-26 Robert Douglas Watson Forming uniform thick oxide layer of material
US3597664A (en) 1969-12-05 1971-08-03 Norton Co Niobium-zirconium-titanium capacitor electrode
JPS5214095A (en) 1975-07-23 1977-02-02 Sumitomo Chemical Co Implant in bone
JPS6036654A (en) 1983-08-06 1985-02-25 Kobe Steel Ltd Treatment of zirconium alloy in autoclave
US5611347A (en) 1989-07-25 1997-03-18 Smith & Nephew, Inc. Zirconium oxide and zirconium nitride coated percutaneous devices
ES2048435T3 (en) * 1989-07-25 1994-03-16 Smith & Nephew Richards Inc PROSTHESIS.
CA2021814C (en) 1989-07-25 2002-04-02 James A. Davidson Zirconium alloy-based prosthesis with zirconium oxide or zirconium nitride coating
US5496359A (en) 1989-07-25 1996-03-05 Smith & Nephew Richards, Inc. Zirconium oxide and zirconium nitride coated biocompatible leads
US5152794A (en) 1989-07-25 1992-10-06 Smith & Nephew Richards Inc. Zirconium oxide and nitride coated prothesis for reduced microfretting
US5477864A (en) 1989-12-21 1995-12-26 Smith & Nephew Richards, Inc. Cardiovascular guidewire of enhanced biocompatibility
US5316594A (en) * 1990-01-18 1994-05-31 Fike Corporation Process for surface hardening of refractory metal workpieces
US5265137A (en) 1990-11-26 1993-11-23 Siemens Power Corporation Wear resistant nuclear fuel assembly components
JPH05220177A (en) * 1992-02-17 1993-08-31 Mitsubishi Materials Corp Implant made of ti base sintered alloy having excellent bioaffinity
EP0562782A3 (en) 1992-03-24 1994-05-25 Smith & Nephew Richards Inc Dual composition coupler for modular medical implants
US5830396A (en) 1993-01-21 1998-11-03 Biomet, Inc. Method for processing thermoplastics, thermosets and elastomers
US5372660A (en) 1993-08-26 1994-12-13 Smith & Nephew Richards, Inc. Surface and near surface hardened medical implants
US5549700A (en) 1993-09-07 1996-08-27 Ortho Development Corporation Segmented prosthetic articulation
MX9603104A (en) * 1994-02-01 1997-03-29 Howmedica Coated femoral stem prosthesis.
CN1054647C (en) * 1994-03-17 2000-07-19 泰利达因工业有限公司 Composite article, alloy and method
DE69600167T2 (en) * 1995-04-03 1998-10-22 Seiko Epson Corp Inkjet printhead and its manufacturing process
CA2205104A1 (en) * 1996-05-10 1997-11-10 Eugenia Ribeiro De Sousa Fidalgo Leitao Device for incorporation and release of biologically active agents
US6043437A (en) 1996-12-20 2000-03-28 Alfred E. Mann Foundation Alumina insulation for coating implantable components and other microminiature devices
DK0968011T3 (en) 1997-03-27 2004-12-20 Smith & Nephew Inc Process for surface oxidation of zirconium alloys and manufactured product
US6585772B2 (en) 1997-03-27 2003-07-01 Smith & Nephew, Inc. Method of surface oxidizing zirconium and zirconium alloys and resulting product
US6013160A (en) * 1997-11-21 2000-01-11 Xerox Corporation Method of making a printhead having reduced surface roughness
DE69906441T2 (en) * 1998-09-15 2004-04-08 Isotis B.V. Coating process for medical implants
EP1415319A2 (en) * 2000-11-29 2004-05-06 Koninklijke Philips Electronics N.V. Picture display device with reduced deflection power
US6726725B2 (en) 2001-06-01 2004-04-27 Smith & Nephew, Inc. Prosthetic devices employing contacting oxidized zirconium surfaces
US6652586B2 (en) 2001-07-18 2003-11-25 Smith & Nephew, Inc. Prosthetic devices employing oxidized zirconium and other abrasion resistant surfaces contacting surfaces of cross-linked polyethylene
US7258810B2 (en) 2001-12-06 2007-08-21 Smith & Nephew, Inc. In-situ oxidized textured surfaces for prosthetic devices and method of making same
US6782910B2 (en) * 2002-03-01 2004-08-31 Lift Technologies, Inc. Multi-function hydraulic valve assembly

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037438A (en) * 1989-07-25 1991-08-06 Richards Medical Company Zirconium oxide coated prosthesis for wear and corrosion resistance
EP0555038A1 (en) * 1992-02-04 1993-08-11 SMITH & NEPHEW RICHARDS, INC. Zirconium oxide and nitride coated cardiovascular implants
WO1994002083A1 (en) * 1992-07-27 1994-02-03 Smith & Nephew Richards Inc. Artificial heart components with improved biocompatible coating
EP0608997A1 (en) * 1993-01-19 1994-08-03 SMITH & NEPHEW RICHARDS, INC. Endoprostheses for tissue protection

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7582117B2 (en) 1997-03-27 2009-09-01 Smith & Nephew Inc. Method of surface oxidizing zirconium and zirconium alloys and resulting product
US6726725B2 (en) 2001-06-01 2004-04-27 Smith & Nephew, Inc. Prosthetic devices employing contacting oxidized zirconium surfaces
WO2002098473A1 (en) * 2001-06-01 2002-12-12 Smith & Nephew, Inc. Prostheses devices employing oxidized zirconium contacting surfaces
AU2002316702B2 (en) * 2001-07-18 2008-04-03 Smith & Nephew, Inc. Prosthetic devices employing oxidized zirconium surfaces contacting surfaces of cross-linked polyethylene
KR100920275B1 (en) * 2001-07-18 2009-10-08 스미스 앤드 네퓨, 인크. Prosthetic devices employing oxidized zirconium surfaces contacting surfaces of cross-linked polyethylene
WO2003008008A1 (en) * 2001-07-18 2003-01-30 Smith & Nephew, Inc. Prosthetic devices employing oxidized zirconium surfaces contacting surfaces of cross-linked polyethylene
JP2009195723A (en) * 2001-07-18 2009-09-03 Smith & Nephew Inc Prosthetic device employing oxidized zirconium surface contacting surface of cross-linked polyethylene
US7182784B2 (en) 2001-07-18 2007-02-27 Smith & Nephew, Inc. Prosthetic devices employing oxidized zirconium and other abrasion resistant surfaces contacting surfaces of cross-linked polyethylene
AU2002330894B2 (en) * 2001-07-20 2008-04-24 Smith & Nephew, Inc. Method of surface oxidizing zirconium and zirconium alloys and resulting product
WO2003008657A1 (en) * 2001-07-20 2003-01-30 Smith & Newphew, Inc. Method of surface oxidizing zirconium and zirconium alloys and resulting product
AU2002360511B2 (en) * 2001-12-06 2008-08-28 Smith & Nephew, Inc. In-situ oxidized textured surfaces for prosthetic devices and method of making same
WO2003049781A1 (en) 2001-12-06 2003-06-19 Smith & Nephew, Inc. In-situ oxidized textured surfaces for prosthetic devices and method of making same
US7258810B2 (en) 2001-12-06 2007-08-21 Smith & Nephew, Inc. In-situ oxidized textured surfaces for prosthetic devices and method of making same
WO2004002543A1 (en) * 2002-06-27 2004-01-08 Smith & Nephew Inc. Prosthetic devices having diffusion-hardened surfaces and bioceramic coatings
EP1433443A1 (en) * 2002-12-27 2004-06-30 Biomet Merck Limited Hip prosthesis with ceramic bearing
US9764061B2 (en) 2004-09-16 2017-09-19 Smith & Nephew, Inc. Method of providing a zirconium surface and resulting product
US10004604B2 (en) 2006-09-08 2018-06-26 Kyocera Corporation Bioimplant for artifical joint with evanescent coating film
US10610614B2 (en) 2006-09-08 2020-04-07 Kyocera Corporation Bioimplant with evanescent coating film
US11278642B2 (en) 2006-09-08 2022-03-22 Takao Hotokebuchi Bioimplant with evanescent coating film
WO2014114944A1 (en) 2013-01-25 2014-07-31 Derek James Wallace Mcminn Prosthesis having a large femoral head
EP2759280A1 (en) 2013-01-25 2014-07-30 McMinn, Derek James Wallace Prosthesis Having a Large Femoral Head
EP3936634A4 (en) * 2019-03-07 2022-01-12 Suzhou Microport Orthorecon Co., Ltd. Preparation method and application of oxidized ceramic layer on surface of zirconium and zirconium alloy
AU2019432095B2 (en) * 2019-03-07 2022-09-08 Suzhou Microport Orthorecon Co., Ltd. Preparation method and application of oxidized ceramic layer on surface of zirconium and zirconium alloy

Also Published As

Publication number Publication date
EP0968011B1 (en) 2004-08-11
JP5632148B2 (en) 2014-11-26
PT968011E (en) 2004-12-31
DK0968011T3 (en) 2004-12-20
CA2284816C (en) 2007-05-15
ATE273036T1 (en) 2004-08-15
JP4491076B2 (en) 2010-06-30
AU736216B2 (en) 2001-07-26
EP0968011A1 (en) 2000-01-05
AU6588998A (en) 1998-10-20
JP2001518827A (en) 2001-10-16
DE69825570D1 (en) 2004-09-16
US7582117B2 (en) 2009-09-01
DE69825570T2 (en) 2005-09-15
JP2010063896A (en) 2010-03-25
US6447550B1 (en) 2002-09-10
ES2227818T3 (en) 2005-04-01
US20060259150A1 (en) 2006-11-16
CA2284816A1 (en) 1998-10-01

Similar Documents

Publication Publication Date Title
US6447550B1 (en) Method of surface oxidizing zirconium alloys and resulting product
US6585772B2 (en) Method of surface oxidizing zirconium and zirconium alloys and resulting product
US9764061B2 (en) Method of providing a zirconium surface and resulting product
US5037438A (en) Zirconium oxide coated prosthesis for wear and corrosion resistance
AU2002330894A1 (en) Method of surface oxidizing zirconium and zirconium alloys and resulting product
US5180394A (en) Zirconium oxide and nitride coated prosthesis for wear and corrosion resistance
US5152794A (en) Zirconium oxide and nitride coated prothesis for reduced microfretting
EP0410711B1 (en) Prosthesis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2284816

Country of ref document: CA

Ref country code: CA

Ref document number: 2284816

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 1998 546015

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 65889/98

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1998912091

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09381217

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1998912091

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 65889/98

Country of ref document: AU

WWG Wipo information: grant in national office

Ref document number: 1998912091

Country of ref document: EP